VolitionRx (NYSEMKT:VNRX) Limited's Cameron (NYSE:CAM) Reynolds updates Proactive on the highlights of its second quarter. The company ended 2Q with a strong balance sheet with about $27.9 million in cash and cash equivalents. Reynolds says the period has seen them make significant progress on many fronts in particular on all four of its key pillars: Nu.Q, Nu.Q Vet, Nu.Q NETs and Nu.Q Capture.
VolitionRx highlights strengthened balance sheet and strong progress on its key pillars in 2Q
